PHARMABCINE INC
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial 2022-02-25 21:00
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
PharmAbcine to Participate in BIO-Europe 2021 2021-09-20 20:00
PharmAbcine to Participate in ACCESS CHINA Biotech Forum 2021-09-13 20:00
PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer 2021-09-09 20:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference 2021-08-23 20:00
PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases 2021-08-19 20:00
PharmAbcine to Participate in Biotechgate Digital Partnering 2021-08-17 20:00
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-05-10 20:00
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-04-26 20:00
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC 2021-04-19 20:00
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021 2021-04-12 20:00
PharmAbcine to Present at AACR Annual Meeting 2021 2021-03-11 21:00
PharmAbcine announces a research collaboration with LegoChem Biosciences 2021-01-11 21:00
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021" 2021-01-04 21:00
PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020 2020-12-09 23:00
PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020 2020-12-07 21:00
1 2 3